Pugashetti J, Khanna D, Kazerooni E, Oldham J
Immunol Allergy Clin North Am. 2023; 43(2):411-433.
PMID: 37055096
PMC: 10584384.
DOI: 10.1016/j.iac.2023.01.012.
Chiu Y, Chu C, Lu C, Liu F, Tang S, Chu S
J Inflamm Res. 2022; 15:2255-2262.
PMID: 35422651
PMC: 9005069.
DOI: 10.2147/JIR.S352085.
Harada Y, Tominaga M, Iitoh E, Kaieda S, Koga T, Fujimoto K
J Clin Med. 2022; 11(7).
PMID: 35407533
PMC: 8999723.
DOI: 10.3390/jcm11071925.
Tomassetti S, Colby T, Wells A, Poletti V, Costabel U, Matucci-Cerinic M
Ther Adv Musculoskelet Dis. 2021; 13:1759720X211059605.
PMID: 34900002
PMC: 8664307.
DOI: 10.1177/1759720X211059605.
Remuzgo-Martinez S, Atienza-Mateo B, Ocejo-Vinyals J, Genre F, Pulito-Cueto V, Mora-Cuesta V
Sci Rep. 2021; 11(1):22574.
PMID: 34799647
PMC: 8604941.
DOI: 10.1038/s41598-021-01992-y.
Prevalence of Nasopharyngeal Carcinoma in Patients with Dermatomyositis: A Systematic Review and Meta-Analysis.
Irekeola A, Shueb R, E A R E, Wada Y, Rahman Z, Ahmad S
Cancers (Basel). 2021; 13(8).
PMID: 33919987
PMC: 8071042.
DOI: 10.3390/cancers13081886.
Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients.
Kurashige T, Takahashi T, Nagano Y, Sugie K, Maruyama H
Neuropathology. 2020; 41(1):29-36.
PMID: 33225515
PMC: 7983952.
DOI: 10.1111/neup.12703.
Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: A meta-analysis.
Zhong D, Wu C, Bai J, Hu C, Xu D, Wang Q
Medicine (Baltimore). 2020; 99(16):e19695.
PMID: 32311947
PMC: 7220682.
DOI: 10.1097/MD.0000000000019695.
Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
Wang Y, Chen S, Lin J, Xie X, Hu S, Lin Q
Rheumatology (Oxford). 2019; 59(8):2024-2029.
PMID: 31794028
PMC: 7382590.
DOI: 10.1093/rheumatology/kez571.
Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
Ye Y, Fu Q, Wang R, Guo Q, Bao C
J Clin Lab Anal. 2019; 33(8):e22978.
PMID: 31301087
PMC: 6805307.
DOI: 10.1002/jcla.22978.
Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study.
Yamaguchi K, Iwamoto H, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S
Medicine (Baltimore). 2018; 97(49):e13542.
PMID: 30544464
PMC: 6310603.
DOI: 10.1097/MD.0000000000013542.
Sequential changes of serum KL-6 predict the progression of interstitial lung disease.
Jiang Y, Luo Q, Han Q, Huang J, Ou Y, Chen M
J Thorac Dis. 2018; 10(8):4705-4714.
PMID: 30233842
PMC: 6129875.
DOI: 10.21037/jtd.2018.07.76.
Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?.
Ikeda S, Arita M, Morita M, Ikeo S, Ito A, Tokioka F
BMC Pulm Med. 2015; 15:159.
PMID: 26651481
PMC: 4675060.
DOI: 10.1186/s12890-015-0154-4.
Immunological biomarkers in dermatomyositis.
Olazagasti J, Niewold T, Reed A
Curr Rheumatol Rep. 2015; 17(11):68.
PMID: 26404949
DOI: 10.1007/s11926-015-0543-y.
Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.
Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M
Arthritis Res Ther. 2015; 17:27.
PMID: 25888887
PMC: 4354987.
DOI: 10.1186/s13075-015-0547-z.
Molecular biomarkers in interstitial lung diseases.
De Lauretis A, Renzoni E
Mol Diagn Ther. 2014; 18(5):505-22.
PMID: 24935523
DOI: 10.1007/s40291-014-0109-0.
Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.
Kiely P, Chua F
Curr Rheumatol Rep. 2013; 15(9):359.
PMID: 23888366
DOI: 10.1007/s11926-013-0359-6.
Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.
Mimori T, Nakashima R, Hosono Y
Curr Rheumatol Rep. 2012; 14(3):264-74.
PMID: 22367479
DOI: 10.1007/s11926-012-0246-6.
Antisynthetase syndrome.
Katzap E, Barilla-Labarca M, Marder G
Curr Rheumatol Rep. 2011; 13(3):175-81.
PMID: 21455765
DOI: 10.1007/s11926-011-0176-8.
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.
Castelino F, Varga J
Arthritis Res Ther. 2010; 12(4):213.
PMID: 20735863
PMC: 2945045.
DOI: 10.1186/ar3097.